India's Coronavirus Vaccine Market offers growth through government-led initiatives, robust manufacturing, and R&D in vaccine ...
Key PointsChikungunya virus (CHIKV) is a mosquito-borne RNA virus first identified in Tanzania in the 1950s.Chikungunya is generally characterized by ...
The global vaccines market is projected to grow from USD 50.46 billion in 2025 to USD 63.66 billion by 2030, achieving a CAGR ...
Vaccine manufacturing is challenged by stringent global regulations, essential for ensuring safety and efficacy, with ...
The training brought together journalists, scientists, and health communicators to deepen their understanding of vaccines, ...
Computational tool improves recombinant virus design efficiency and yield.This innovative in-house development is a key component of Transgene’s ...
A new vaccine candidate against Lassa fever, one of West Africa’s deadliest diseases, has shown strong and long-lasting ...
AllAfrica on MSN
Encouraging Results From a First-in-Human Phase 1 Clinical Trial of IAVI's Lassa Vaccine Candidate Published in New England Journal of Medicine
One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways: IAVI's Lassa vaccine candidate rVSVΔG-LASV-GPC has an acceptable safety profile and ...
Raccoon Rabies Control Program uses baited vaccine blocks to prevent rabies spread among raccoons, feral cats and other ...
AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side ...
Cambridge, Massachusetts Wednesday, November 19, 2025, 16:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback